Trichorovin-Ia
| Internal ID | b1572405-7134-4aa2-a7ec-48826943c4a3 |
| Taxonomy | Organic acids and derivatives > Carboxylic acids and derivatives > Amino acids, peptides, and analogues > Peptides |
| IUPAC Name | 2-[(2-acetamido-2-methylpropanoyl)amino]-N-[1-[[1-[[1-[2-[[1-[[1-[[1-[2-[(1-hydroxy-3-methylbutan-2-yl)carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]butanediamide |
| SMILES (Canonical) | CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)N1CCCC1C(=O)NC(CO)C(C)C)NC(=O)C2CCCN2C(=O)C(C)(C)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CC(=O)N)NC(=O)C(C)(C)NC(=O)C |
| SMILES (Isomeric) | CC(C)CC(C(=O)NC(CC(C)C)C(=O)NC(C)(C)C(=O)N1CCCC1C(=O)NC(CO)C(C)C)NC(=O)C2CCCN2C(=O)C(C)(C)NC(=O)C(CC(C)C)NC(=O)C(C(C)C)NC(=O)C(CC(=O)N)NC(=O)C(C)(C)NC(=O)C |
| InChI | InChI=1S/C56H98N12O13/c1-29(2)24-35(44(72)58-36(25-30(3)4)46(74)65-55(14,15)53(81)68-23-19-21-41(68)49(77)61-39(28-69)32(7)8)59-48(76)40-20-18-22-67(40)52(80)56(16,17)66-47(75)37(26-31(5)6)60-50(78)43(33(9)10)63-45(73)38(27-42(57)71)62-51(79)54(12,13)64-34(11)70/h29-33,35-41,43,69H,18-28H2,1-17H3,(H2,57,71)(H,58,72)(H,59,76)(H,60,78)(H,61,77)(H,62,79)(H,63,73)(H,64,70)(H,65,74)(H,66,75) |
| InChI Key | KNWLCGPPEUQMGB-UHFFFAOYSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C56H98N12O13 |
| Molecular Weight | 1147.40 g/mol |
| Exact Mass | 1146.73763123 g/mol |
| Topological Polar Surface Area (TPSA) | 366.00 Ų |
| XlogP | 2.30 |
| Atomic LogP (AlogP) | -0.10 |
| H-Bond Acceptor | 13 |
| H-Bond Donor | 11 |
| Rotatable Bonds | 30 |
| RefChem:191247 |
| 2-((1-hydroxy-2-((1-hydroxyethylidene)amino)-2-methylpropylidene)amino)-N-(1-((1-((1-(2-((1-((1-((1-(2-((1-hydroxy-3-methylbutan-2-yl)-C-hydroxycarbonimidoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)-C-hydroxycarbonimidoyl)-3-methylbutyl)-C-hydroxycarbonimidoyl)-3-methylbutyl)-C-hydroxycarbonimidoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)-C-hydroxycarbonimidoyl)-3-methylbutyl)-C-hydroxycarbonimidoyl)-2-methylpropyl)butanediimidate |
| 2-((2-acetamido-2-methylpropanoyl)amino)-N-(1-((1-((1-(2-((1-((1-((1-(2-((1-hydroxy-3-methylbutan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)butanediamide |
| 2-({1-hydroxy-2-[(1-hydroxyethylidene)amino]-2-methylpropylidene}amino)-N-{1-[(1-{[1-(2-{[1-({1-[(1-{2-[(1-hydroxy-3-methylbutan-2-yl)-C-hydroxycarbonimidoyl]pyrrolidin-1-yl}-2-methyl-1-oxopropan-2-yl)-C-hydroxycarbonimidoyl]-3-methylbutyl}-C-hydroxycarbonimidoyl)-3-methylbutyl]-C-hydroxycarbonimidoyl}pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl]-C-hydroxycarbonimidoyl}-3-methylbutyl)-C-hydroxycarbonimidoyl]-2-methylpropyl}butanediimidate |
| 2-[(2-acetamido-2-methylpropanoyl)amino]-N-[1-[[1-[[1-[2-[[1-[[1-[[1-[2-[(1-hydroxy-3-methylbutan-2-yl)carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]butanediamide |
| CHEBI:211737 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.4868 | 48.68% |
| Caco-2 | - | 0.8599 | 85.99% |
| Blood Brain Barrier | - | 0.6750 | 67.50% |
| Human oral bioavailability | - | 0.6143 | 61.43% |
| Subcellular localzation | Lysosomes | 0.6841 | 68.41% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8844 | 88.44% |
| OATP1B3 inhibitior | + | 0.9340 | 93.40% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.9385 | 93.85% |
| P-glycoprotein inhibitior | + | 0.7428 | 74.28% |
| P-glycoprotein substrate | + | 0.8232 | 82.32% |
| CYP3A4 substrate | + | 0.7035 | 70.35% |
| CYP2C9 substrate | - | 0.7929 | 79.29% |
| CYP2D6 substrate | - | 0.8494 | 84.94% |
| CYP3A4 inhibition | - | 0.8046 | 80.46% |
| CYP2C9 inhibition | - | 0.8726 | 87.26% |
| CYP2C19 inhibition | - | 0.8076 | 80.76% |
| CYP2D6 inhibition | - | 0.8875 | 88.75% |
| CYP1A2 inhibition | - | 0.9067 | 90.67% |
| CYP2C8 inhibition | - | 0.6284 | 62.84% |
| CYP inhibitory promiscuity | - | 0.9743 | 97.43% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.7800 | 78.00% |
| Carcinogenicity (trinary) | Non-required | 0.6344 | 63.44% |
| Eye corrosion | - | 0.9797 | 97.97% |
| Eye irritation | - | 0.8968 | 89.68% |
| Skin irritation | - | 0.7668 | 76.68% |
| Skin corrosion | - | 0.8934 | 89.34% |
| Ames mutagenesis | - | 0.5900 | 59.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.3925 | 39.25% |
| Micronuclear | + | 0.6400 | 64.00% |
| Hepatotoxicity | + | 0.6157 | 61.57% |
| skin sensitisation | - | 0.8504 | 85.04% |
| Respiratory toxicity | + | 0.7444 | 74.44% |
| Reproductive toxicity | + | 0.7778 | 77.78% |
| Mitochondrial toxicity | + | 0.7000 | 70.00% |
| Nephrotoxicity | + | 0.5425 | 54.25% |
| Acute Oral Toxicity (c) | III | 0.6463 | 64.63% |
| Estrogen receptor binding | + | 0.7084 | 70.84% |
| Androgen receptor binding | + | 0.7421 | 74.21% |
| Thyroid receptor binding | + | 0.5842 | 58.42% |
| Glucocorticoid receptor binding | + | 0.6842 | 68.42% |
| Aromatase binding | + | 0.7236 | 72.36% |
| PPAR gamma | + | 0.7789 | 77.89% |
| Honey bee toxicity | - | 0.8444 | 84.44% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.7000 | 70.00% |
| Fish aquatic toxicity | - | 0.6004 | 60.04% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.58% | 98.95% |
| CHEMBL3468 | P55210 | Caspase-7 | 99.44% | 95.68% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.33% | 96.61% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 98.30% | 98.94% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.15% | 97.25% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.98% | 98.33% |
| CHEMBL4801 | P29466 | Caspase-1 | 97.68% | 96.85% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.64% | 96.09% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 97.41% | 98.10% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 96.99% | 92.38% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.79% | 93.56% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 96.41% | 96.67% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 95.68% | 94.66% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 94.80% | 100.00% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 94.77% | 96.03% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 94.62% | 94.00% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 94.61% | 97.50% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 93.87% | 98.24% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 93.19% | 100.00% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 93.18% | 97.43% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 93.16% | 96.47% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 92.94% | 95.38% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 92.46% | 97.14% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 92.37% | 98.89% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 92.36% | 100.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 92.18% | 97.09% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 92.08% | 97.64% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 91.78% | 91.19% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 91.76% | 92.12% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 91.23% | 83.14% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 91.20% | 96.31% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 90.59% | 83.10% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 89.79% | 92.80% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 89.69% | 97.29% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 89.64% | 99.77% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 89.00% | 96.67% |
| CHEMBL204 | P00734 | Thrombin | 88.27% | 96.01% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 87.76% | 90.08% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.55% | 94.33% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 86.94% | 88.42% |
| CHEMBL1801 | P00747 | Plasminogen | 86.83% | 92.44% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 86.59% | 93.33% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 86.22% | 96.95% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 86.14% | 90.71% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 86.04% | 93.00% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 85.58% | 95.71% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 85.34% | 98.05% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 85.16% | 81.29% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 84.93% | 98.77% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 84.76% | 97.86% |
| CHEMBL5028 | O14672 | ADAM10 | 84.70% | 97.50% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 84.65% | 94.45% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 84.20% | 95.89% |
| CHEMBL2334 | P42574 | Caspase-3 | 84.10% | 98.25% |
| CHEMBL3351 | Q13085 | Acetyl-CoA carboxylase 1 | 83.85% | 93.04% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 83.85% | 95.52% |
| CHEMBL3776 | Q14790 | Caspase-8 | 83.72% | 97.06% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 83.70% | 95.27% |
| CHEMBL2781 | P19634 | Sodium/hydrogen exchanger 1 | 83.67% | 90.24% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 83.54% | 95.17% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 83.53% | 97.47% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 83.31% | 93.10% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 83.28% | 94.45% |
| CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 83.26% | 98.57% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 83.26% | 87.16% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.26% | 100.00% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 82.54% | 90.93% |
| CHEMBL3691 | Q13822 | Autotaxin | 82.38% | 96.39% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 82.11% | 97.21% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 82.04% | 91.11% |
| CHEMBL2095194 | P08709 | Coagulation factor VII/tissue factor | 81.81% | 99.17% |
| CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 81.68% | 97.56% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 81.68% | 98.75% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 81.59% | 97.50% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 81.22% | 99.18% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 81.17% | 95.50% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 81.04% | 93.03% |
| CHEMBL2140 | P48775 | Tryptophan 2,3-dioxygenase | 80.50% | 98.46% |
| CHEMBL3474 | P14555 | Phospholipase A2 group IIA | 80.37% | 94.05% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 80.17% | 90.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Ajuga reptans |
| PubChem | 139588343 |
| LOTUS | LTS0186104 |
| wikiData | Q105141695 |